Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 7.82
(0.13%)
CNY 7.82
(0.13%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 158.79 Million CNY | 4.39% |
| 2022 | 179.66 Million CNY | 17.71% |
| 2021 | 152.62 Million CNY | 38.35% |
| 2020 | 110.32 Million CNY | 10.59% |
| 2019 | 99.75 Million CNY | 27.26% |
| 2018 | 78.38 Million CNY | 16.59% |
| 2017 | 67.23 Million CNY | 26.95% |
| 2016 | 52.95 Million CNY | -15.44% |
| 2015 | 62.63 Million CNY | -14.68% |
| 2014 | 73.4 Million CNY | 131.98% |
| 2013 | 31.64 Million CNY | 234.52% |
| 2012 | 9.45 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 48.26 Million CNY | -9.57% |
| 2024 Q1 | 53.37 Million CNY | 100.15% |
| 2024 Q3 | 51.43 Million CNY | 6.56% |
| 2023 Q2 | 72.19 Million CNY | 69.7% |
| 2023 Q3 | 46.15 Million CNY | -36.07% |
| 2023 FY | 187.55 Million CNY | 4.39% |
| 2023 Q1 | 42.54 Million CNY | -1.56% |
| 2023 Q4 | 26.66 Million CNY | -42.22% |
| 2022 Q4 | 43.21 Million CNY | -32.37% |
| 2022 Q2 | 46.11 Million CNY | 74.38% |
| 2022 Q1 | 26.44 Million CNY | -37.6% |
| 2022 FY | 179.66 Million CNY | 17.71% |
| 2022 Q3 | 63.89 Million CNY | 38.57% |
| 2021 Q2 | 38.14 Million CNY | 25.93% |
| 2021 FY | 152.62 Million CNY | 38.35% |
| 2021 Q1 | 30.29 Million CNY | 40.73% |
| 2021 Q4 | 42.37 Million CNY | 1.33% |
| 2021 Q3 | 41.81 Million CNY | 9.63% |
| 2020 Q3 | 23.05 Million CNY | -41.3% |
| 2020 Q2 | 39.27 Million CNY | 48.38% |
| 2020 FY | 110.32 Million CNY | 10.59% |
| 2020 Q1 | 26.46 Million CNY | -28.05% |
| 2020 Q4 | 21.52 Million CNY | -6.64% |
| 2019 Q3 | 27.44 Million CNY | 44.21% |
| 2019 Q2 | 19.03 Million CNY | 15.48% |
| 2019 Q1 | 16.48 Million CNY | -31.12% |
| 2019 FY | 99.75 Million CNY | 27.26% |
| 2019 Q4 | 36.78 Million CNY | 34.01% |
| 2018 Q1 | 11.62 Million CNY | -56.53% |
| 2018 Q3 | 21.02 Million CNY | -3.56% |
| 2018 Q2 | 21.8 Million CNY | 87.58% |
| 2018 FY | 78.38 Million CNY | 16.59% |
| 2018 Q4 | 23.93 Million CNY | 13.8% |
| 2017 FY | 67.23 Million CNY | 26.95% |
| 2017 Q3 | 15.79 Million CNY | 10.17% |
| 2017 Q2 | 14.33 Million CNY | 38.35% |
| 2017 Q1 | 10.36 Million CNY | -44.27% |
| 2017 Q4 | 26.73 Million CNY | 69.28% |
| 2016 Q1 | 10.25 Million CNY | 0.0% |
| 2016 Q3 | 12.81 Million CNY | 13.51% |
| 2016 Q2 | 11.29 Million CNY | 10.15% |
| 2016 Q4 | 18.59 Million CNY | 45.03% |
| 2016 FY | 52.95 Million CNY | -15.44% |
| 2015 FY | 62.63 Million CNY | -14.68% |
| 2015 Q1 | 10.78 Million CNY | 0.0% |
| 2014 FY | 73.4 Million CNY | 131.98% |
| 2013 FY | 31.64 Million CNY | 234.52% |
| 2012 FY | 9.45 Million CNY | 0.0% |